Navigation Links
Amgen Statement on European Investor Visit
Date:11/14/2011

our competitors.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.  In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products.  Discovery or identification of new product candidates cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate will be successful and become a commercial product.  Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers.  Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)  

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained.
2. Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale
3. Amgen Announces Webcast of 2011 Third Quarter Financial Results
4. Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress
5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
6. Amgen to Present at the Morgan Stanley Global Healthcare Conference
7. Amgen to Present at the Baird Healthcare Conference
8. Amgen to Present at the Stifel Nicolaus Healthcare Conference
9. Amgen Announces PDUFA Date for XGEVA® Supplemental Biologics License Application
10. Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion
11. Amgen Announces Webcast of 2011 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... and technology platform company serving the pharmaceutical, biotechnology, and ... United States, today announced its financial results for the ... Fourth-Quarter 2014 Highlights , Net Revenues Increased 21.3% ... Services Net Revenues Grew 17.7% Year Over Year to ...
(Date:3/5/2015)... and TÜBINGEN, Germany , ... Melinda Gates Foundation and CureVac today announced that ... $52 million (€46 million) in CureVac, a leading ... As part of the agreement, the foundation will ... develop prophylactic vaccines based on CureVac,s proprietary messenger ...
(Date:3/5/2015)... 5, 2015 CANTEL MEDICAL CORP. (NYSE: ... ended January 31, 2015 on Thursday, March 12 before the ... results at 11:00 AM ET. To participate ... 10 minutes before the beginning of the call. If you ... will be available from Thursday, March 12, 2015 through midnight ...
Breaking Medicine Technology:WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 20WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 21WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 22The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
... ... Salt Lake City based software company, announces the launch of a new ... in conjunction with existing in-office therapy methods. , eyeQ was ... elect, Dr. Brad Habermehl believes the eyeQ program adds significant ...
... , FRANKLIN, Mass., Nov. 24 ... company developing its needle-free Symphony(TM) tCGM System as a ... its Prelude(TM) SkinPrep System for transdermal drug delivery, announced ... Executive Officer, will present at the 13th Annual Biotech ...
Cached Medicine Technology:Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 2Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
(Date:3/6/2015)... March 06, 2015 Parents need to ... reality of substance use disorders. School programs like DARE, ... marginally successful. NOPE, or Narcotics Overdose Prevention and Education ... to Healthline News on Feb. 27th. As ... prescription opiate drugs, drug prevention proponents are lobbying Florida ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... 06, 2015 Further solidifying their position ... Doctor Associates announced today that the company has earned ... the Best of Staffing Talent Award five years in ... of Staffing Talent Diamond winners are proven industry leaders ... them by the individuals they have helped find temporary ...
(Date:3/6/2015)... Cailfornia (PRWEB) March 06, 2015 ... technology company, announced today the launch of its ... money on healthy and sustainable products at any ... Makeena is exhibiting at Expo West Booth 6054. ... search by gluten-free, Kosher, non-GMO, organic, Paleo, and ...
Breaking Medicine News(10 mins):Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3
... group from Bradford's St Luke's Hospital, gauged the cost-benefit of ... hospital into the community, and said that there was no ... ,Indeed cost savings has been the driving force behind the ... studying the costs of rehabilitating 220 senior patients, recouping from ...
... potential economic cost of HIV epidemic could be substantial, says ... costs to the economy arising from the continued and unchecked ... to the report released here Thursday, based on a study ... (NCAER) with the support of state-run National AIDS Control Organisation ...
... A new test for esophageal reflux disease developed by ... been licensed to Bayer HealthCare’s Diagnostics Division by WFUHS.// ... pepsin 3b in a patient’s saliva, was developed by ... Forest University School of Medicine and director of WFUHS’s ...
... influenza virus while plans are in place to vaccinate the ... form of bird flu. Dr. Thonton said that other bird ... avian influenza virus. ,The highly pathogenic bird flu ... the year 2003.It remains difficult for humans to contact the ...
... as a potential provider of artificial blood, indeed considered a ... through our veins, very much our lifeline has always been ... blood during complex surgeries to save the life of the ... in store, and a little worm which is popularly called ...
... has approved the use of Gardasil, cervical cancer vaccine ... use in a national// immunization program. ,The ... of Human Papilloma Virus (HPV) which is a common ... sexually active adults sometime during their life, it is ...
Cached Medicine News:Health News:HIV Epidemic Can Slow Down Economic Growth: UNDP 2Health News:Test for Esophageal Reflux Licensed to Bayer by University 2Health News:A Worm Turns: Banking on Blood From a Little Lugworm 2
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
ROB-NEL Catheters (100% Latex-Free)...
Red Rubber Robinson Catheters (Latex)...
Urethral Red Rubber Catheters (Latex)...
Medicine Products: